Myriad Genetics Earnings Preview
Portfolio Pulse from Benzinga Insights
Myriad Genetics (NASDAQ:MYGN) is expected to report an EPS of $0.01 in its upcoming quarterly earnings on 2024-02-27. Historically, the company has had mixed earnings performance but has shown a positive trend in stock price over the last 52 weeks, with a 20.35% increase. Investors are looking for not just an earnings beat but also positive guidance for future growth.
February 26, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Myriad Genetics is anticipated to report an EPS of $0.01 for the upcoming quarter. Historical performance shows a positive trend in stock price following earnings announcements, with a significant 20.35% increase over the last 52 weeks.
Given Myriad Genetics' history of stock price increases following earnings beats and the overall positive trend in the past year, there is a strong likelihood of a positive short-term impact on MYGN's stock price if the company meets or exceeds the EPS estimate and provides favorable future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100